Macleods Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 65.00 Cr
- Paid Up Capital ₹ 64.87 Cr
- Company Age 35 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 481.13 Cr
- Satisfied Charges ₹ 131.64 Cr
- Revenue Growth 5.77%
- Profit Growth 26.40%
- Ebitda -8.19%
- Net Worth 27.47%
- Total Assets 24.65%
About Macleods Pharmaceuticals
Macleods Pharmaceuticals Ltd (MPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 05 June 1989 and has a history of 35 years and eight months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Macleods Pharmaceuticals Pvt Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 65.00 Cr and a paid-up capital of Rs 64.87 Cr.
The company currently has active open charges totaling ₹481.13 Cr. The company has closed loans amounting to ₹131.64 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Macleods Pharmaceuticals Ltd India are Vijay Agarwal as Ceo, Siddhesh Rane as Company Secretary, and Mukesh Agarwal as Cfo. Banwarilal Bawri, Girdharilal Bawri, Rajendra Agarwal, and Three other members serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239MH1989PLC052049
- Company No.
052049
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
05 Jun 1989
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Macleods Pharmaceuticals Ltd offer?
Macleods Pharmaceuticals Ltd offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Medicine, Marketing Services & Consultants, Marketing Services, Health Conditions, Heart Care, Women Care, Women Care Supplements, Kidney Care, Mother Care.
Who are the key members and board of directors at Macleods Pharmaceuticals?
Executive Team (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Banwarilal Bawri  | Managing Director | 05-Jun-1989 | Current |
| Rajendra Agarwal | Managing Director | 05-Jun-1989 | Current |
| Vijay Agarwal | CEO | 09-Feb-2022 | Current |
| Siddhesh Rane | Company Secretary | 18-Dec-2018 | Current |
| Mukesh Agarwal | CFO | 24-Oct-2024 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Girdharilal Bawri | Director | 22-May-1990 | Current |
| Vinita Danait | Director | 09-Feb-2022 | Current |
| Mihir Shah | Director | 01-Jul-2016 | Current |
| Arvind Mokashi | Director | 09-Feb-2022 | Current |
Financial Performance of Macleods Pharmaceuticals.
Macleods Pharmaceuticals Ltd, for the financial year ended 2023, experienced modest growth in revenue, with a 5.77% increase. The company also saw a substantial improvement in profitability, with a 26.4% increase in profit. The company's net worth Soared by an impressive increase of 27.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Macleods Pharmaceuticals?
In 2023, Macleods Pharmaceuticals had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Surya Lakshmi Cotton Mills LtdArvind Mokashi is a mutual person
Pmea Solar Systems Private LimitedVinita Danait is a mutual person
Terracis Digital LimitedArvind Mokashi is a mutual person
Credit Wise Capital Private LimitedArvind Mokashi is a mutual person
Macleods Laboratories Private LimitedBanwarilal Bawri and Rajendra Agarwal are mutual person
- Ratnidevi Murlidhar Bawri Social Welfare Foundation
Girdharilal Bawri and Rajendra Agarwal are mutual person
Charges (Loans)
₹481.13 Cr
₹131.64 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 299.70 Cr
- Standard Chartered Bank : 71.50 Cr
- Hdfc Bank Limited : 59.93 Cr
- Axis Bank Limited : 50.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Jul 2021 | Standard Chartered Bank | ₹71.50 Cr | Open |
| 21 Jun 2021 | Hdfc Bank Limited | ₹59.93 Cr | Open |
| 26 Apr 2021 | Axis Bank Limited | ₹50.00 Cr | Open |
| 07 Sep 2020 | State Bank Of India | ₹299.70 Cr | Open |
| 26 Apr 2021 | Others | ₹61.92 Cr | Satisfied |
How Many Employees Work at Macleods Pharmaceuticals?
Macleods Pharmaceuticals has a workforce of 20172 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Macleods Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Macleods Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
